Medicinal Cannabis for Inflammatory Bowel Disease: A Survey of Perspectives, Experiences, and Current Use in Australian Patients

BACKGROUND: Medicinal cannabis (MC) is an increasingly utilized treatment option for various refractory diseases. While robust clinical evidence supporting MC efficacy in inflammatory bowel disease (IBD) is lacking, many IBD patients report using MC to obtain symptomatic relief. Understanding this u...

Descripción completa

Detalles Bibliográficos
Autores principales: Benson, Melissa J, Abelev, Sarah V, Connor, Susan J, Corte, Crispin J, Martin, Lewis J, Gold, Lucy K, Suraev, Anastasia S, McGregor, Iain S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802391/
https://www.ncbi.nlm.nih.gov/pubmed/36777301
http://dx.doi.org/10.1093/crocol/otaa015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802391/
https://www.ncbi.nlm.nih.gov/pubmed/36777301
http://dx.doi.org/10.1093/crocol/otaa015

Ejemplares similares